Location
United States, North America
Cheque size
$100K - $5M
Investment Stage
Seed
Series B
Focus Areas
BioTech
Pharmaceuticals
About Investor
Ash Khanna is a Partner at Pivotal bioVenture Partners, based in the San Francisco Bay Area. He focuses on biotech, pharmaceuticals, and diagnostics, from seed through Series B. His typical check sizes range from $100K – $5M. Ash brings deep domain expertise in life sciences, backing companies advancing novel therapeutics and healthcare innovations.
Previous investments
Evommune
50M |2023
83M |2021
13M |2020
HotSpot Therapeutics
100M |2021
Bolt Biotherapeutics
94M |2020
54M |2019
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.